Search research articles
Contact Us
Filters
Showing results (31-40 of 136) with videos related to
Page
of 14
Sort By:
The Urologic Clinics of North America
|
June 26, 2026
Patient-Centered Approaches to Non-Muscle-Invasive Bladder Cancer Care
Melinda Z Fu, Jennifer Sykes, John Pfail, et al.
Urology
|
August 27, 2016
Reply by the Authors
Vignesh T Packiam, Andrew J Cohen, Joseph J Pariser, et al.
Current Opinion in Urology
|
March 20, 2021
The current landscape of salvage therapies for patients with bacillus Calmette-Guérin unresponsive nonmuscle invasive bladder cancer
Vignesh T Packiam, Jordan Richards, Maximilian Schmautz, et al.
Current Urology Reports
|
June 14, 2016
Trends in Simple Prostatectomy for Benign Prostatic Hyperplasia
Joseph J Pariser, Vignesh T Packiam, Melanie A Adamsky, et al.
BJU International
|
October 20, 2023
Alternative instillation techniques of sequential intravesical gemcitabine and docetaxel for non-muscle-invasive bladder cancer
Ian M McElree, Sarah L Mott, Michael A O'Donnell, et al.
Journal of Endourology
|
May 19, 2018
Bladder Reconstruction with Bowel: Robot-Assisted Laparoscopic Ileocystoplasty with Mitrofanoff Appendicovesicostomy in Pediatric Patients
Nimrod S Barashi, Maria Veronica Rodriguez, Vignesh T Packiam, et al.
Urology Case Reports
|
May 1, 2026
Tumor-informed ctDNA surveillance after radical nephrectomy and level IV IVC thrombectomy for clear cell renal cell carcinoma: Early detection of molecular residual disease
Mahdi Hemmati Ghavshough, Melinda Z Fu, Disha Patel, et al.
European Urology Oncology
|
November 4, 2024
Reply to Wen-Wei Sung's Letter to the Editor re: Wei Shen Tan, Ian M. McElree, Facundo Davaro, et al. Sequential Intravesical Gemcitabine and Docetaxel Is an Alternative to Bacillus Calmette-Guérin for the Treatment of Intermediate-risk Non-muscle-invasive Bladder Cancer. Eur Urol Oncol. In press. https://doi.org/10.1016/j.euo.2023.06.011
Wei Shen Tan, Michael O'Donnell, Roger Li, et al.
Urology Case Reports
|
May 9, 2022
Combined robotic radical prostatectomy and laparoscopic proctectomy for synchronous prostate and rectal cancer
Zachary Tully, Jordan Richards, Asgeir T Masson, et al.
Asian Journal of Urology
|
November 12, 2021
The emerging role of somatic tumor sequencing in the treatment of urothelial cancer
Lexiaochuan Wen, Cameron J Britton, Rohan Garje, et al.
Page
of 14
Search research articles
Search
Showing results (31-40 of 136) with videos related to
Sort By:
Page
of 14
The Urologic Clinics of North America
|
June 26, 2026
Patient-Centered Approaches to Non-Muscle-Invasive Bladder Cancer Care
Melinda Z Fu, Jennifer Sykes, John Pfail, et al.
Urology
|
August 27, 2016
Reply by the Authors
Vignesh T Packiam, Andrew J Cohen, Joseph J Pariser, et al.
Current Opinion in Urology
|
March 20, 2021
The current landscape of salvage therapies for patients with bacillus Calmette-Guérin unresponsive nonmuscle invasive bladder cancer
Vignesh T Packiam, Jordan Richards, Maximilian Schmautz, et al.
Current Urology Reports
|
June 14, 2016
Trends in Simple Prostatectomy for Benign Prostatic Hyperplasia
Joseph J Pariser, Vignesh T Packiam, Melanie A Adamsky, et al.
BJU International
|
October 20, 2023
Alternative instillation techniques of sequential intravesical gemcitabine and docetaxel for non-muscle-invasive bladder cancer
Ian M McElree, Sarah L Mott, Michael A O'Donnell, et al.
Journal of Endourology
|
May 19, 2018
Bladder Reconstruction with Bowel: Robot-Assisted Laparoscopic Ileocystoplasty with Mitrofanoff Appendicovesicostomy in Pediatric Patients
Nimrod S Barashi, Maria Veronica Rodriguez, Vignesh T Packiam, et al.
Urology Case Reports
|
May 1, 2026
Tumor-informed ctDNA surveillance after radical nephrectomy and level IV IVC thrombectomy for clear cell renal cell carcinoma: Early detection of molecular residual disease
Mahdi Hemmati Ghavshough, Melinda Z Fu, Disha Patel, et al.
European Urology Oncology
|
November 4, 2024
Reply to Wen-Wei Sung's Letter to the Editor re: Wei Shen Tan, Ian M. McElree, Facundo Davaro, et al. Sequential Intravesical Gemcitabine and Docetaxel Is an Alternative to Bacillus Calmette-Guérin for the Treatment of Intermediate-risk Non-muscle-invasive Bladder Cancer. Eur Urol Oncol. In press. https://doi.org/10.1016/j.euo.2023.06.011
Wei Shen Tan, Michael O'Donnell, Roger Li, et al.
Urology Case Reports
|
May 9, 2022
Combined robotic radical prostatectomy and laparoscopic proctectomy for synchronous prostate and rectal cancer
Zachary Tully, Jordan Richards, Asgeir T Masson, et al.
Asian Journal of Urology
|
November 12, 2021
The emerging role of somatic tumor sequencing in the treatment of urothelial cancer
Lexiaochuan Wen, Cameron J Britton, Rohan Garje, et al.
Page
of 14